Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Jan 15;97(2):359–365. doi: 10.1172/JCI118423

A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide.

J E Somerville Jr 1, L Cassiano 1, B Bainbridge 1, M D Cunningham 1, R P Darveau 1
PMCID: PMC507025  PMID: 8567955

Abstract

A unique screen was used to identify mutations in Escherichia coli lipid A biosynthesis that result in a decreased ability to stimulate E-selectin expression by human endothelial cells. A mutation was identified in the msbB gene of E. coli that resulted in lipopolysaccharide (LPS) that lacks the myristoyl fatty acid moiety of the lipid A. Unlike all previously reported lipid A mutants, the msbB mutant was not conditionally lethal for growth. Viable cells or purified LPS from an msbB mutant had a 1000-10,000-fold reduction in the ability to stimulate E-selectin production by human endothelial cells and TNF alpha production by adherent monocytes. The cloned msbB gene was able to functionally complement the msbB mutant, restoring both the LPS to its native composition and the ability of the strain to stimulate immune cells. Nonmyristoylated LPS acted as an antagonist for E-selectin expression when mixed with LPS obtained from the parental strain. These studies demonstrate a significant role for the myristate component of LPS in immune cell activation and antagonism. In addition, the msbB mutant allowed us to directly examine the crucial role that the lipid A structure plays when viable bacteria are presented to host defense cells.

Full Text

The Full Text of this article is available as a PDF (206.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akiyama Y., Kamitani S., Kusukawa N., Ito K. In vitro catalysis of oxidative folding of disulfide-bonded proteins by the Escherichia coli dsbA (ppfA) gene product. J Biol Chem. 1992 Nov 5;267(31):22440–22445. [PubMed] [Google Scholar]
  2. Bardwell J. C., McGovern K., Beckwith J. Identification of a protein required for disulfide bond formation in vivo. Cell. 1991 Nov 1;67(3):581–589. doi: 10.1016/0092-8674(91)90532-4. [DOI] [PubMed] [Google Scholar]
  3. Brozek K. A., Raetz C. R. Biosynthesis of lipid A in Escherichia coli. Acyl carrier protein-dependent incorporation of laurate and myristate. J Biol Chem. 1990 Sep 15;265(26):15410–15417. [PubMed] [Google Scholar]
  4. Christ W. J., Asano O., Robidoux A. L., Perez M., Wang Y., Dubuc G. R., Gavin W. E., Hawkins L. D., McGuinness P. D., Mullarkey M. A. E5531, a pure endotoxin antagonist of high potency. Science. 1995 Apr 7;268(5207):80–83. doi: 10.1126/science.7701344. [DOI] [PubMed] [Google Scholar]
  5. Couturier C., Haeffner-Cavaillon N., Caroff M., Kazatchkine M. D. Binding sites for endotoxins (lipopolysaccharides) on human monocytes. J Immunol. 1991 Sep 15;147(6):1899–1904. [PubMed] [Google Scholar]
  6. Darveau R. P., Cunningham M. D., Bailey T., Seachord C., Ratcliffe K., Bainbridge B., Dietsch M., Page R. C., Aruffo A. Ability of bacteria associated with chronic inflammatory disease to stimulate E-selectin expression and promote neutrophil adhesion. Infect Immun. 1995 Apr;63(4):1311–1317. doi: 10.1128/iai.63.4.1311-1317.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fischer W. Purification and fractionation of lipopolysaccharide from gram-negative bacteria by hydrophobic interaction chromatography. Eur J Biochem. 1990 Dec 12;194(2):655–661. doi: 10.1111/j.1432-1033.1990.tb15665.x. [DOI] [PubMed] [Google Scholar]
  8. Frey E. A., Miller D. S., Jahr T. G., Sundan A., Bazil V., Espevik T., Finlay B. B., Wright S. D. Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med. 1992 Dec 1;176(6):1665–1671. doi: 10.1084/jem.176.6.1665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jorgensen R. A., Rothstein S. J., Reznikoff W. S. A restriction enzyme cleavage map of Tn5 and location of a region encoding neomycin resistance. Mol Gen Genet. 1979;177(1):65–72. doi: 10.1007/BF00267254. [DOI] [PubMed] [Google Scholar]
  10. Karow M., Fayet O., Cegielska A., Ziegelhoffer T., Georgopoulos C. Isolation and characterization of the Escherichia coli htrB gene, whose product is essential for bacterial viability above 33 degrees C in rich media. J Bacteriol. 1991 Jan;173(2):741–750. doi: 10.1128/jb.173.2.741-750.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Karow M., Georgopoulos C. Isolation and characterization of the Escherichia coli msbB gene, a multicopy suppressor of null mutations in the high-temperature requirement gene htrB. J Bacteriol. 1992 Feb;174(3):702–710. doi: 10.1128/jb.174.3.702-710.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lee J. D., Kravchenko V., Kirkland T. N., Han J., Mackman N., Moriarty A., Leturcq D., Tobias P. S., Ulevitch R. J. Glycosyl-phosphatidylinositol-anchored or integral membrane forms of CD14 mediate identical cellular responses to endotoxin. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9930–9934. doi: 10.1073/pnas.90.21.9930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Loppnow H., Brade H., Dürrbaum I., Dinarello C. A., Kusumoto S., Rietschel E. T., Flad H. D. IL-1 induction-capacity of defined lipopolysaccharide partial structures. J Immunol. 1989 May 1;142(9):3229–3238. [PubMed] [Google Scholar]
  14. Mattsby-Baltzer I., Mielniczuk Z., Larsson L., Lindgren K., Goodwin S. Lipid A in Helicobacter pylori. Infect Immun. 1992 Oct;60(10):4383–4387. doi: 10.1128/iai.60.10.4383-4387.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ogawa T. Chemical structure of lipid A from Porphyromonas (Bacteroides) gingivalis lipopolysaccharide. FEBS Lett. 1993 Oct 11;332(1-2):197–201. doi: 10.1016/0014-5793(93)80512-s. [DOI] [PubMed] [Google Scholar]
  16. Pohlman T. H., Munford R. S., Harlan J. M. Deacylated lipopolysaccharide inhibits neutrophil adherence to endothelium induced by lipopolysaccharide in vitro. J Exp Med. 1987 May 1;165(5):1393–1402. doi: 10.1084/jem.165.5.1393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Pugin J., Schürer-Maly C. C., Leturcq D., Moriarty A., Ulevitch R. J., Tobias P. S. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2744–2748. doi: 10.1073/pnas.90.7.2744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Raetz C. R. Bacterial endotoxins: extraordinary lipids that activate eucaryotic signal transduction. J Bacteriol. 1993 Sep;175(18):5745–5753. doi: 10.1128/jb.175.18.5745-5753.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Somerville J. E., Kahn M. L. Cloning of the glutamine synthetase I gene from Rhizobium meliloti. J Bacteriol. 1983 Oct;156(1):168–176. doi: 10.1128/jb.156.1.168-176.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Takayama K., Din Z. Z., Mukerjee P., Cooke P. H., Kirkland T. N. Physicochemical properties of the lipopolysaccharide unit that activates B lymphocytes. J Biol Chem. 1990 Aug 15;265(23):14023–14029. [PubMed] [Google Scholar]
  21. Vukajlovich S. W., Morrison D. C. Conversion of lipopolysaccharides to molecular aggregates with reduced subunit heterogeneity: demonstration of LPS-responsiveness in "endotoxin-unresponsive" C3H/HeJ splenocytes. J Immunol. 1983 Jun;130(6):2804–2808. [PubMed] [Google Scholar]
  22. Wright S. D., Ramos R. A., Hermanowski-Vosatka A., Rockwell P., Detmers P. A. Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14. J Exp Med. 1991 May 1;173(5):1281–1286. doi: 10.1084/jem.173.5.1281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Wright S. D., Ramos R. A., Tobias P. S., Ulevitch R. J., Mathison J. C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 1990 Sep 21;249(4975):1431–1433. doi: 10.1126/science.1698311. [DOI] [PubMed] [Google Scholar]
  24. Yanisch-Perron C., Vieira J., Messing J. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene. 1985;33(1):103–119. doi: 10.1016/0378-1119(85)90120-9. [DOI] [PubMed] [Google Scholar]
  25. de Bruijn F. J., Lupski J. R. The use of transposon Tn5 mutagenesis in the rapid generation of correlated physical and genetic maps of DNA segments cloned into multicopy plasmids--a review. Gene. 1984 Feb;27(2):131–149. doi: 10.1016/0378-1119(84)90135-5. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES